Answers are grounded in this paper and cite their sources.
Introduction: Novel coronavirus disease (Covid-19) has been recognized as a new human infectious disease caused by a mutated type of coronavirus that might be associated with thrombocytopenia through different mechanisms. Moreover, the presence of underlying disease is a risk of hospitalization and poor prognosis of Covid-19. Case report: Here, we describe a 77-year-old male Covid-19 patient with essential thrombocythemia. Although gastrointestinal symptoms (GI) were uncommon in the early stages of the pandemic, he presented to a clinic with GI symptoms and general weakness. He didn't have any respiratory involvement and laboratory tests revealed a hemoglobin and platelet reduction (810000/micL to 174000/micL), leukopenia, and elevated D-dimer. He received oseltamivir (75 mg twice daily) and hydroxychloroquine (200 mg twice daily) for five days. Discussion & Conclusions: Despite his underlying disease and severity of illness including one-month fever, malaise, and a weight loss of 11 kg in ten days, he was cured without any hospitalization.
No takes yet. Share an insight, caveat, or question.
Talaie et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: